ReviewFrontiers in neuroscience2025
Unraveling the complexity of cognitive impairment following high-altitude exposure: from preclinical animal models to human organoids.
Review in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neural-behavioral dissociation under acute high-altitude stress: an exploratory ERP study of non-specific neural recruitment and rTMS effects.Frontiers in behavioral neuroscience · 2026Article
- Microbiota-gut-brain axis imbalance: a promising therapeutic target for preserving brain health in high-altitude environment.Frontiers in neuroscience · 2026Review
- Alterations in static and dynamic topological properties of brain functional network after chronic high altitude exposure: a panel study.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-term exposure to high-altitude hypobaric hypoxia has a detrimental effect on cognitive function. These effects are dependent on multiple factors, including altitude, exposure duration, pre-acclimatization conditions, psychological traits, and individual differences. Existing studies have investigated pathogenesis, epidemiology, and interventions for hypobaric hypoxia-associated cognitive impairment based on population studies and preclinical models. The underlying pathophysiological mechanisms involve energy metabolism, neuronal autophagy, oxidative stress, inflammatory response, gut microbiota imbalances, and genetic susceptibility. However, no consensus has been reached on the most important mechanisms and most recommended animal models, and no standard effective interventions are currently available. This review aims to provide new insights and research perspectives for cognitive impairment following high-altitude exposure. By systematically summarizing the pathophysiological mechanisms of hypobaric hypoxia-associated cognitive impairment, we comprehensively compare animal models for studying high-altitude-induced cognitive decline using three paradigms, i.e., mild, moderate, and extreme high-altitude exposure. Additionally, we introduce various
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.